Related to the collybistin mutations, rare mutations have also been identified in gephyrin associated with diverse NDD diagnoses (Table 2), including ASD, seizures, and schizophrenia (Lionel et al., 2013). This evidence concerns the gene GPHN and Neurodevelopmental delay.